Ariel S. Gross
National Institutes of Health(US)National Institute of Diabetes and Digestive and Kidney Diseases(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Synthesis and Biological Evaluation, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors(2003)134 cited
- → Structure–activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists(2003)126 cited
- → Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and Antagonists(2003)120 cited
- → Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor(2003)83 cited
- → Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands(2004)56 cited
- → Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position(2004)46 cited
- → Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety(2003)34 cited
- → 2,2′-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding(2004)32 cited
- → Effects of the allosteric modulator SCH-202676 on adenosine and P2Y receptors(2004)25 cited
- → Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety(2004)20 cited